On-demand webinar
Biotherapies
Solutions
You will receive an email with a link to the webinar
Biotherapies
In August 2010, Kristin Kleinhofer was diagnosed with acute lymphoblastic leukemia (ALL) and began a two-year journey of intense in-patient chemotherapy that ultimately failed to keep her in remission.
Under the recommendation of her medical team, Kristin enrolled in an early Phase I/II clinical trial of chimeric antigen receptor T-cell therapy at Fed Hutchinson Cancer Center in November 2014.
Today, nine years later, Kristin shows no evidence of disease and is passionate about patient advocacy efforts, mentoring fellow cancer patients and caregivers, sharing her message of hope and partnering with cancer research and supporting nonprofits.
Listen in on this recorded webinar where Kristin shares her incredible story and how the latest developments in transplantation and cellular therapy changed her life.
Fill out the form provided to receive the recording and a copy of the presentation slides.
Watch now
Recorded Oct 23, 2018
WellSky only wants to send you the information you are interested in. Please fill out the form below to choose the emails you want to receive. We only send emails to subscribers. If you are an existing customer, you will continue to receive certain notifications.
In August 2010, Kristin Kleinhofer was diagnosed with acute lymphoblastic leukemia (ALL) and began a two-year journey of intense in-patient chemotherapy that ultimately failed to keep her in remission. By February 2014, the cancer had returned. With the support of her partner, Benny, and her mother, she began seeking immunotherapy clinical trial options after standard salvage chemotherapy and Phase II combination chemotherapy clinical trial efforts failed. Under the recommendation of her medical team, Kristin enrolled in an early Phase I/II clinical trial of chimeric antigen receptor T-cell therapy at Fred Hutchinson Cancer Center in November 2014. Kristin was among the 93% of patients with ALL in early clinical trial results that reached remission. She then enrolled in a randomized Phase II clinical trial in February 2015, also taking place at the Fred Hutchinson Cancer Center, which used double umbilical cord blood as the donor source for her stem cell transplant, as she had no match in the registry or within the family. Today, nine years later, Kristin continues to remain cancer-free and is passionate about patient advocacy efforts, mentoring fellow cancer patients and caregivers, sharing her message of hope and partnering with cancer research and supporting nonprofits.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.
WellSky is a technology company that delivers software and services to transform an ever-growing range of care services worldwide. Building on a history of excellence and a reputation for quality, WellSky – formerly Mediware Information Systems and Kinnser Software – empowers providers to provide exceptional care, improve operational efficiency, reduce cost, and meet the challenges of their rapidly changing industries.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly. So they're able to anticipate — and exponentially increase — the impact of care.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly. So they're able to anticipate — and exponentially increase — the impact of care.